Consequences to Patients, Clinicians, and Manufacturers When Very Serious Adverse Drug Reactions Are Identified (1997–2019): A Qualitative Analysis from the Southern Network on Adverse Reactions (SONAR)
Crossref DOI link: https://doi.org/10.1007/978-3-031-04402-1_10
Published Online: 2022-12-01
Published Print: 2022
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lubaczewski, Courtney R.
Olivieri, Nancy F.
Hrushesky, William R.
Bennett, Charles L.
Text and Data Mining valid from 2022-01-01
Version of Record valid from 2022-01-01
Chapter History
First Online: 1 December 2022